July 12, 2016 Cancer hospital advertising triples since 2005 Between 2005 and 2014, U.S. cancer centers upped their spending on ads targeting the general public, with 890 centers spending $173 million on ads by 2014, according to a new analysis.
June 30, 2016 Following prevention guidelines linked to lowered risk for cancer Keeping active and eating healthy really does seem to reduce the odds of getting certain cancers and dying from them, according to a new review of past research.
June 27, 2016 Racially biased cancer doctors spend less time with black patients Racial bias on the part of a doctor can lead to poor communication and medical treatment for black cancer patients, a U.S. study suggests.
June 9, 2016 Scientists decipher 11 subtypes in acute leukemia gene study Scientists unpicking the gene faults behind an aggressive blood cancer called acute myeloid leukemia (AML) have found it is not a single disease, but at least 11 different ones with important differences for patients' likely survival chances.
May 27, 2016 New HIV vaccine trial aims to build on earlier modest success A late-stage trial will begin later this year in South Africa to test the effectiveness of an HIV vaccine that has shown promise in earlier trials, according to the National Institutes of Health.
May 23, 2016 Young female cancer survivors not clear on infertility risks Many young women who survive cancer don't understand how tumor treatments affect their reproductive health even though the therapy can trigger infertility, a survey suggests.
May 17, 2016 HIV-infected patients less likely to get cancer treatment HIV-infected cancer patients are much less likely to receive treatment for tumors than people who don't have the virus, a large U.S. study suggests.
May 11, 2016 Mandatory flu shots tied to surge in health worker vaccinations Mandatory vaccination policies may encourage more healthcare workers to get annual flu shots and help prevent the spread of influenza to patients, a study in one Texas health system suggests.
May 6, 2016 2nd baby gets Cellectis 'designer' cells to clear leukemia A second baby with aggressive leukemia has been treated in London with "designer immune cells" developed by Cellectis and, six months after treatment, she remains in remission, the French biotech firm said on Friday.
May 4, 2016 Polluted air may up risk of many cancers For elderly people in Hong Kong, long term exposure to fine-particle air pollution is tied to an increased risk of dying from many cancers, including breast, liver and pancreatic cancer, in addition to the expected lung cancer risk, according to a new study.
